Atria Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Atria Investments’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$392K	Sell	5,227 -428	-8%	-$33.8K	﹤0.01%	1582
2025 Q4	$447K	Sell	5,655 -1,375	-20%	-$104K	0.01%	1514
2025 Q3	$460K	Sell	7,030 -1,156	-14%	-$56.4K	0.01%	1466
2025 Q2	$323K	Buy	+8,186	New	+$268K	﹤0.01%	1678
2020 Q1	–	Sell	-7,233	Closed	-$437K	–	859
2019 Q4	$437K	Buy	7,233 +3,545	+96%	+$211K	0.01%	835
2019 Q3	$221K	Sell	3,688 -1,092	-23%	-$71.2K	0.01%	813
2019 Q2	$320K	Sell	4,780 -1,852	-28%	-$131K	0.01%	719
2019 Q1	$538K	Sell	6,632 -961	-13%	-$62K	0.02%	515
2018 Q4	$410K	Buy	7,593 +522	+7%	+$26.6K	0.02%	566
2018 Q3	$365K	Buy	+7,071	New	+$332K	0.01%	696

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atria Investments's IONS Position: Q1 2026 in Review

Atria Investments reduced its Ionis Pharmaceuticals (IONS) stake by 7.6% in Q1 2026, selling an estimated $33.8K and leaving 5,227 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

Atria Investments first reported a position in IONS in Q3 2018 and has held it in 10 quarters since. The position peaked at $538K in Q1 2019. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Atria Investments held 5,227 shares of Ionis Pharmaceuticals worth $392K as of Q1 2026.
Atria Investments sold 428 Ionis Pharmaceuticals shares in Q1 2026, an estimated $33.8K.
Ionis Pharmaceuticals made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1582 holding.
Atria Investments first reported a position in Ionis Pharmaceuticals in Q3 2018 and has held it in 10 quarters since.
Atria Investments's Ionis Pharmaceuticals position peaked at $538K in Q1 2019.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.